课题基金 / 基金详情

Stem cell homing/engraftment in lung injury and repair

Stem cell homing/engraftment in lung injury and repair
干细胞归巢/植入在肺损伤和修复中的作用
批准号:
6659923
负责人:
Zea Borok
金额:
$24.38万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-11 至 2005-07-31

项目摘要

项目成果

Zea Borok的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供): 对啮齿动物的移植研究表明,损伤后,器官可以由从骨髓招募的前体细胞重新填充,这表明成年鼠骨髓来源的干细胞具有相当大的可塑性。鉴定人骨髓中的全能未支配干细胞群对于包括肺在内的受损器官的再生将具有巨大的临床益处,并提示通过外源性注射免疫相容的干细胞来再生损伤后的肺泡上皮的可能性。这项建议的目的是确定产生肺泡上皮细胞表型的人类干细胞群体和植入环境,长期目标是促进损伤后肺泡再上皮化和肺功能的恢复。我们假设:1)骨髓来源的人类干细胞的特定亚群在体内移植到小鼠体内或在体外培养时具有不同的谱系潜力,由肺微环境决定;2)人类干细胞在肺内植入并在体外和体内向肺泡上皮表型分化是由已知的肺损伤后局部释放的生长因子促进的。基于我们在干细胞和肺泡上皮细胞生物学方面的专业知识、已建立的人类移植异种移植模型和肺泡上皮细胞体外培养系统的可用性,我们将通过以下具体目标来研究这些假说:1)研究分离的人类干细胞在肺损伤后重新填充免疫缺陷小鼠远端肺上皮的能力;2)体外分析微环境对分离的人类干细胞分化的影响。这项拟议的研究将调查特定人群的人骨髓来源干细胞(间充质干细胞贴壁和造血细胞非贴壁)在受损肺泡上皮中再生的能力,并比较静脉和气管内给药的效率。将采用体外和体内相结合的方法来评估局部肺环境中增加人类干细胞募集或诱导向远端肺上皮表型分化的因素(例如肝细胞生长因子和角质形成细胞生长因子)。鉴定具有分化细胞类型的成人干细胞群体将为损伤后的肺(和其他器官)的修复提供非凡的治疗潜力。
英文摘要
DESCRIPTION (provided by applicant): Transplantation studies in rodents indicate that following injury, organs can be repopulated by precursor cells recruited from bone marrow, suggesting considerable plasticity of marrow-derived stem cells in the adult. Identification of a totipotent uncommitted stem cell population in human bone marrow would be of enormous clinical benefit for regeneration of injured organs including the lung, and suggests the possibility for repopulation of the pulmonary alveolar epithelium following injury by exogenously administered immunologically compatible stem cells. The objective of this proposal is to define human stem cell populations and implantation environments that generate lung alveolar epithelial cell phenotypes, with the long-range goal of improving alveolar reepithelialization and restoration of lung function following injury. We hypothesize that: 1) specific subsets of marrow-derived human stem cells have different lineage potential determined by the lung microenvironment when transplanted into mice in vivo or when cultured in vitro, and 2) human stem cell engraftment in the lung and differentiation towards an alveolar epithelial phenotype in vitro and in vivo is enhanced by growth factors known to be released locally following lung injury. Capitalizing on our combined expertise in stem and alveolar epithelial cell biology, availability of established xenograft models for human transplantation and in vitro systems for alveolar epithelial cell culture, we will investigate these hypotheses by addressing the following Specific Aims: 1) Investigate the ability of fractionated human stem cells to repopulate the distal lung epithelium of immune deficient mice following lung injury and 2) Analyze in vitro the effects of microenvironment on differentiation of fractionated human stem cells. The proposed studies will investigate the capacity of defined populations of human marrow-derived stem cells (mesenchymal plastic-adherent vs. hematopoietic non-adherent) to repopulate the injured alveolar epithelium, and compare the efficiency of intravenous vs. intratracheal administration. A combination of in vitro and in vivo approaches will be applied to evaluate factors (e.g., hepatocyte growth factor and keratinocyte growth factor) in the local lung milieu that augment human stem cell recruitment or induce differentiation towards a distal lung epithelial phenotype. Identification of an adult human stem cell population with the ability to generate differentiated cell types would offers extraordinary therapeutic potential for repair of the lungs (and other organs) following injury.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deciphering the Link between Severe Acute Respiratory Coronavirus 2 Infection and Long-Term Neurological and Pulmonary Sequelae
Beyond the Barrier: Alveolar Epithelial Cell Biology in Health and Disease
Beyond the Barrier: Alveolar Epithelial Cell Biology in Health and Disease
Beyond the Barrier: Alveolar Epithelial Cell Biology in Health and Disease
海外基金